Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
Citigroup
C
|
+$374M |
| 3 |
Amazon
AMZN
|
+$352M |
| 4 |
XL
XL Group Ltd.
XL
|
+$284M |
| 5 |
PPG Industries
PPG
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$288M |
| 2 |
Union Pacific
UNP
|
+$283M |
| 3 |
JPMorgan Chase
JPM
|
+$238M |
| 4 |
AGN
Allergan plc
AGN
|
+$226M |
| 5 |
Archer Daniels Midland
ADM
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 8.85% |
| 2 | Financials | 7.52% |
| 3 | Industrials | 6.64% |
| 4 | Energy | 5.78% |
| 5 | Technology | 5.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHUY
3701
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $959K | ﹤0.01% |
+48,755
| New | +$1.2M |
|
|
OAK
3702
PUT
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $959K | ﹤0.01% |
18,500
+8,400
| +83% | +$406K |
|
|
ENZ
3703
DELISTED
Enzo Biochem, Inc.
ENZ
| $958K | ﹤0.01% |
215,919
+37,632
| +21% | +$179K |
|
3704
America Movil
AMX
$70.3B
| $957K | ﹤0.01% |
43,152
+17,616
| +69% | +$410K |
|
3705
PUT
Flowserve
FLS
$10.3B
| $957K | ﹤0.01% |
16,000
-8,300
| -34% | -$528K |
|
3706
Invesco Solar ETF
TAN
$1.36B
| $956K | ﹤0.01% |
28,041
+10,815
| +63% | +$387K |
|
3707
FIVE9
FIVN
$2.47B
| $952K | ﹤0.01% |
212,409
+1,907
| +0.9% | +$8.87K |
|
|
WCG
3708
PUT
DELISTED
Wellcare Health Plans, Inc.
WCG
| $952K | ﹤0.01% |
11,600
-33,100
| -74% | -$2.31M |
|
3709
PUT
Lear
LEA
$8.32B
| $951K | ﹤0.01% |
9,700
-5,400
| -36% | -$496K |
|
|
LTM
3710
PUT
DELISTED
LIFE TIME FITNESS INC
LTM
| $951K | ﹤0.01% |
16,800
-2,600
| -13% | -$139K |
|
3711
PUT
Avery Dennison
AVY
$13.6B
| $949K | ﹤0.01% |
18,300
+15,100
| +472% | +$717K |
|
3712
Cytokinetics
CYTK
$10.3B
| $949K | ﹤0.01% |
118,464
+32,366
| +38% | +$139K |
|
3713
PUT
Rayonier Advanced Materials
RYAM
$570M
| $948K | ﹤0.01% |
42,500
+29,700
| +232% | +$786K |
|
3714
PUT
Diana Shipping
DSX
$309M
| $947K | ﹤0.01% |
201,962
+54,639
| +37% | +$295K |
|
3715
PUT
Protolabs
PRLB
$2.2B
| $947K | ﹤0.01% |
14,100
-8,600
| -38% | -$565K |
|
3716
PUT
Carlyle Group
CG
$17.6B
| $946K | ﹤0.01% |
34,400
+13,600
| +65% | +$386K |
|
|
DNY
3717
PUT
DELISTED
DONNELLEY R R & SONS CO
DNY
| $946K | ﹤0.01% |
56,300
-16,100
| -22% | -$271K |
|
|
SRGA
3718
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $945K | ﹤0.01% |
6,059
+2,715
| +81% | +$391K |
|
3719
Navios Maritime Partners
NMM
$2.33B
| $944K | ﹤0.01% |
6,192
+4,422
| +250% | +$921K |
|
|
ARG
3720
PUT
DELISTED
Airgas Inc
ARG
| $944K | ﹤0.01% |
8,200
+1,100
| +15% | +$124K |
|
|
3721
CALL
Lear
LEA
$8.32B
| $942K | ﹤0.01% |
9,600
-13,500
| -58% | -$1.24M |
|
3722
iShares Dow Jones US ETF
IYY
$3.09B
| $941K | ﹤0.01% |
+18,192
| New | +$920K |
|
3723
CALL
Xerox
XRX
$407M
| $941K | ﹤0.01% |
25,768
-7,097
| -22% | -$250K |
|
|
FWP
3724
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $941K | ﹤0.01% |
+6,454
| New | +$931K |
|
3725
PUT
IMAX
IMAX
$2.9B
| $939K | ﹤0.01% |
30,400
+17,700
| +139% | +$518K |
|
Similar funds
Ken Griffin's Q4 2014 Portfolio in Review
As of Q4 2014, Ken Griffin held 9,167 positions worth $102B, up 6.5% from $95.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ken Griffin's Q4 2014 filing shows 1,076 new, 3,582 increased, 3,580 reduced and 702 closed positions. Its largest new stake was SIGMA - ALDRICH CORP: 1,469,606 shares worth $202M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $288M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 8.8% of assets, up from 7.6% a quarter earlier, followed by Financials and Industrials.
- Ken Griffin's largest Q4 2014 buy was SIGMA - ALDRICH CORP: 1,469,606 shares worth $202M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.04B increase.
- Ken Griffin's biggest Q4 2014 reduction was Union Pacific, cutting an estimated $283M.
- Ken Griffin fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, selling an estimated $288M.
- Ken Griffin's ten largest holdings make up 16% of its $102B portfolio in Q4 2014.
- Ken Griffin opened 1,076 new positions and closed 702 in Q4 2014.
- Ken Griffin's portfolio value rose 6.5% quarter-over-quarter to $102B.
Based on Citadel Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.